People | February 18, 2022
LEO Pharma appoints Brian Hilberdink President of LEO Pharma, US
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
The aim is to strengthen industry-academia cooperation
The cash consideration for the acquisition is US$ 18 million.
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
_256_384.jpg)
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
The approval allows it to market its products in the country
These five oxygen plants with a total capacity of 3,840 cubic meters of oxygen per day have been donated to Madhya Pradesh, Maharashtra, and Gujarat
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Subscribe To Our Newsletter & Stay Updated
